120. CCA Practice Quiz: Subcutaneous Infusion Therapy for Pain Medication

Subcutaneous infusion therapy questions ask you to sort out access, medication delivery, safety concerns, and CCA role limits. You will see direct knowledge, comparisons, application questions, and short judgment situations. The focus stays on recognizing key differences, understanding why this therapy is used, and applying role and delegation limits without turning the quiz into a lesson.

Start the Quiz!

 

Results

You passed, great job!

You showed good understanding of the subcutaneous infusion therapy material tested here, including access, medication delivery, and CCA role limits. If any questions felt uncertain, review that area, then try another attempt for a different selection from the question bank.

You’re not there yet, but you’re getting practice.

Review the explanations, look at the questions you missed, then try again. Mistakes show you what to study next.

Need a refresher before retaking it? Study this topic here.

#1. Which detail matches both the tissue location and practice standard for subcutaneous infusion access?

Correct answer: B. A port or small needle enters subcutaneous tissue, using Standard Practices.

Explanation: The injection port or small needle is inserted into the subcutaneous tissue layer using Standard Practices. The access itself, rather than the IV tubing, enters the tissue.

Why A is wrong: Vein access describes an intravenous route rather than this subcutaneous route.
Why C is wrong: The access enters the subcutaneous tissue rather than resting only on the surface.
Why D is wrong: The port or small needle forms the tissue access, not the IV tubing itself.

#2. What does intravenous, IV, therapy mean?

Correct answer: D. Fluids given through a needle or catheter inserted into a vein

Explanation: IV therapy involves fluids delivered through a needle or catheter inserted into a vein. The location of the access distinguishes IV therapy from subcutaneous infusion.

Why A is wrong: A topical patch does not describe IV therapy.
Why B is wrong: A subcutaneous port uses subcutaneous tissue rather than a vein.
Why C is wrong: Access placed in subcutaneous tissue is not intravenous access.

#3. Which statement explains how subcutaneous infusion reduces repeated skin injections?

Correct answer: A. Pain medication enters through the subcutaneous port instead of a new skin injection.

Explanation: Pain medication is administered into the injection port rather than through a separate skin injection for each dose. This feature addresses the need for frequent repeated injections.

Why B is wrong: Vein access describes an intravenous route rather than the stated subcutaneous medication route.
Why C is wrong: The port is used for medication delivery, not merely to support tubing.
Why D is wrong: Giving each dose through a new skin injection would defeat the stated purpose of the port.

#4. Which group of problems is associated with numerous pain-medication injections?

Correct answer: A. Discomfort, possible infection, and skin problems

Explanation: Numerous injections are associated with discomfort and possible infection or skin problems around injection sites. These problems help explain why reducing repeated injections matters.

Why B is wrong: Port movement and loss of vein access are different issues.
Why C is wrong: Topical-patch effectiveness and vein irritation do not describe the stated group of repeated-injection problems.
Why D is wrong: IV tubing and vein access do not describe the stated injection-site concerns.

#5. A subcutaneous port becomes dislodged. Which statement best links that change to pain relief?

Correct answer: B. The port might leave subcutaneous tissue, so medication through it might not relieve pain.

Explanation: A dislodged port or needle might come out of the subcutaneous tissue. Medication given through an access that is no longer correctly positioned might fail to provide the intended pain relief.

Why A is wrong: Secure tape does not establish that a dislodged access remains in the required tissue layer.
Why C is wrong: Movement does not turn a subcutaneous access into intravenous access.
Why D is wrong: The concern is the changed position of the subcutaneous access, not a change in topical-patch function.

#6. A regulated health care professional delegates a task outside standard CCA practice. Which set matches its approval, client-specific, and care-plan requirements?

Correct answer: B. Employer-approved, client or situation specific, and included in the care plan

Explanation: An outside-standard delegated task requires employer approval, needs to be client or situation specific, and needs to appear in the care plan. Other delegation requirements address preparation and supervision.

Why A is wrong: It includes preparation requirements but omits employer approval and care-plan inclusion.
Why C is wrong: It includes employer approval but substitutes preparation and supervision requirements for the other two requested conditions.
Why D is wrong: It includes the care plan but does not include employer approval or client or situation specificity.

#7. The subcutaneous port or needle becomes dislodged. Which response includes both required actions?

Correct answer: A. Apply pressure with sterile gauze using Standard Practices and contact the supervisor immediately.

Explanation: A dislodged port or needle requires pressure with sterile gauze using Standard Practices and immediate contact with the supervisor. Both parts belong to the response.

Why B is wrong: Sterile gauze pressure is included, but the immediate supervisor contact is missing.
Why C is wrong: Immediate supervisor contact is included, but the sterile gauze pressure is missing.
Why D is wrong: Maintaining position applies to an intact access and does not complete the response to dislodgement.

#8. Which setup matches the tubing connection and securing of the subcutaneous access?

Correct answer: C. IV tubing connects to the port or needle, which is securely taped to skin.

Explanation: IV tubing is connected to the subcutaneous injection port or needle. The access is then securely taped to the client’s skin.

Why A is wrong: A vein catheter describes intravenous access rather than the subcutaneous setup being tested.
Why B is wrong: A topical patch is different from the port or needle used for this therapy.
Why D is wrong: Separate injection sites do not describe the infusion setup.

Previous
Finish